ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2026, Vol. 35 ›› Issue (5): 481-485.DOI: 10.3969/j.issn.1006-298X.2026.05.016

• 血液净化 • 上一篇    下一篇

腹膜透析相关真菌性腹膜炎的临床研究进展

  

  • 出版日期:2026-10-27 发布日期:2026-10-27

Clinical research progress of peritoneal dialysis-related fungal peritonitis

  • Online:2026-10-27 Published:2026-10-27

摘要:

真菌性腹膜炎(fungal peritonitis,FP)是腹膜透析危重并发症,病死率高。近年病原谱由白念珠菌向非白念珠菌变迁,与长期使用抗生素、低白蛋白血症、糖尿病等密切相关。传统真菌培养检出滞后,宏基因组二代测序等新型手段可实现早期诊断;临床核心方案为尽早拔除透析导管并进行个体化抗真菌治疗,高危人群预防性抗真菌治疗可降低发病风险。本文围绕FP病原、诊断、治疗与预防展开综述,为临床规范化诊疗提供循证依据。

Abstract:

Fungal peritonitis (FP) is a serious complication of peritoneal dialysis whichs cause high mortality. In recent years, there has been a shift in the pathogen spectrum from Candida albicans to non-albicans Candida species, which is closely associated with long-term antibiotic use, hypoalbuminemia, diabetes mellitus and other risk factors. The detection of traditional fungal culture is lagging behind, and the metagenomic next-generation sequencing (mNGS) can achieve early diagnosis; the clinical core plan is to remove the dialysis catheter as soon as possible and carry out individualized antifungal therapy, prophylactic antifungal therapy in high-risk groups. Prophylactic antifungal therapy can reduce the risk of disease. This article reviews the etiology, diagnosis, treatment and prevention of FP, and provides evidence-based reference for clinical standardized diagnosis and treatment.

中图分类号: